Trials / Unknown
UnknownNCT01466842
Ablation as First Line Treatment in Paroxysmal Atrial Fibrillation
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- Sponsor
- Maastricht University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether catheter ablation is more effective than antiarrhythmic drugs in the early stages of paroxysmal atrial fibrillation. In all the patients a subcutaneous loop recorder will be implanted.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Catheter ablation using cryothermia | Three months before the catheter ablation procedure, a subcutaneous loop recorder will be implanted. The ablation procedure will be performed using cryothermia. |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2013-01-01
- Completion
- 2016-01-01
- First posted
- 2011-11-08
- Last updated
- 2011-11-08
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01466842. Inclusion in this directory is not an endorsement.